With its recently published study “Global Nebulizers and Inhalers Market – Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025”, Infoholic Research forecasts that the nebulizers and inhalers market is expected to grow at a steady rate, CAGR of 7.5%, during the forecast period 2019–2025. The increase in the prevalence of chronic respiratory diseases is a significant factor fuelling the growth of the global nebulizers and inhalers market. According to the publication by WHO in 2017, an estimated 65 million people had a moderate-to-severe chronic obstructive pulmonary disease (COPD), among which about 3 million die each year. The increase in the incidence of chronic respiratory diseases, rising geriatric population, and desk-bound lifestyle of people globally have increased the demand for home care therapeutic devices, which is anticipated to impetus in the future. Home care provides personal care for chronic diseases and is quite common among the old-age population. The emergence of smart devices with the integration of microprocessors will play a big role in the next period of inhaler and nebulizer development, allowing improved patient communication and self-management as well as monitoring of adherence to treatment. However, this market is largely influenced by simple techniques of care offered by home healthcare gadgets with greater compliance that help patients to manage themselves in an emergency condition.

Get a sample copy of the report @ https://www.infoholicresearch.com/request-a-sample-report/?repid=14504

The overall market is segmented as nebulizers (ultrasonic, {pneumatic nebulizers [breath-enhanced and breath-actuated]}, mesh nebulizers {active and passive}]) and inhalers (dry powder inhaler and meter dose inhaler). Nebulizers provide a more consistent means for delivering drug mist with a very specific diameter and at controlled flow rates. The future of nebulization technology is very promising and fascinating. Recent advancements in the development of nebulizers have made drug delivery more precise, less wasteful, and potentially much easier to use during inhalation therapy. Also, new types of nebulizers have yielded several improvements, i.e., compact design, portability, shorter treatment duration, and quick operation that are expected to improve patient adherence to therapy. Among all types, pneumatic nebulizers are widely used by patients. The key factors driving the market include easy operative nature as well as cost-effectiveness when compared to other nebulizers. There are various types of respiratory inhaler devices available in the market: metered-dose inhaler (MDI) and dry powder inhaler. MDI constitutes the largest market share among inhalation systems followed by dry powder inhalers, which are used in treating cystic fibrosis, a life-threatening lung disease.

Home care settings are expected to witness the highest growth during the forecast period, mainly due to the convenience and comfort in a home care environment, coupled with cost advantages. The most critical factor responsible for creating opportunities in the home care segment is an increase in the number of aged and physically handicap people. However, the availability of low-cost products from local manufacturers and home healthcare practitioners is expected to increase the adoption of nebulizers and inhalers, assisting patients in remote areas or those generally away from physicians.

Access Full Report Summary @ https://www.infoholicresearch.com/report/nebulizers-and-inhalers-market/

North America dominates the global nebulizers and inhalers market due to the continuous innovations in technology with a growing aging population followed by a fast-moving lifestyle. Europe is expected to be the second-largest region in terms of revenue share owing to the presence of several manufacturing companies that provide a huge marketplace for nebulizers and inhalers. Asia Pacific is expected to be the fastest regional market for respiratory devices owing to the increased incidence of asthma & other respiratory diseases in industrial regions and exposure to more indoor air pollution than smoking or outdoor air pollution. According to the University of Washington’s Global Burden of Disease study, COPD was the second-highest cause of death in India after heart disease in 2017, killing 1 million (958,000) Indians that particular year, however, the risk factors include hereditary conditions, biomass fuel, and environmental pollution.

“Nebulizers and inhalers are growing rapidly due to an increase in demand for non-invasive therapies over other modes of treatment. The promising technologies and higher compliance of products are helping patients to adhere to their medication, reducing respiratory disorders symptoms. The availability of advanced ergonomically featured products is expected to boost the market growth with a significant rise in smart and digital nebulizers and inhalers. Further, the companies are continuously focusing on providing the best delivery mode of medicine to asthmatic patients to target unmet medical needs.” – Mohammed Azhar, Team Lead (Research – Healthcare) at Infoholic Research

Key Segments of the Report Include:

• By Product Type:
  • Nebulizers – Ultrasonic Nebulizers, Pneumatic Nebulizers (Breath-enhanced and Breath-actuated), and Mesh Nebulizers (Active Mesh Nebulizers and Passive Mesh Nebulizers)
  • Inhalers – Dry Powder Inhaler and Meter Dose Inhaler
• By End-users
  • Hospitals
  • Ambulatory Care Centers
  • Home Care
• By Regions:
  • North America
  • Europe
  • APAC
  • RoW

• Industry outlook: Market trends, drivers, restraints, and opportunities

Contact: